Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. APUS
APUS logo

APUS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Apimeds Pharmaceuticals US Inc (APUS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.880
1 Day change
7.43%
52 Week Range
40.310
Analysis Updated At
2026/04/02
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

APUS is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows weak technical indicators, no positive trading signals, and lacks strong financial performance or catalysts to support a bullish outlook.

Technical Analysis

The technical indicators are bearish. The MACD is below 0 and negatively contracting, RSI indicates the stock is oversold, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Additionally, the stock has weak support and resistance levels, with invalid S2 data.

Positive Catalysts

  • NULL identified. There is no recent news or significant trading activity by insiders or hedge funds.

Neutral/Negative Catalysts

  • The stock has a high chance of declining in the short term based on candlestick pattern analysis (-1.16% in the next week, -1.49% in the next month). Financial performance is weak with no revenue, negative net income, and negative EPS despite YoY improvements.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY), negative net income of -1,781,255 (up 435.68% YoY), and an EPS of -0.14 (up 366.67% YoY). Gross margin remains at 0%. Overall, the financials indicate a struggling company with no clear growth trajectory.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes available.

Wall Street analysts forecast APUS stock price to rise
Analyst Rating
0
Wall Street analysts forecast APUS stock price to rise
Buy
Hold
Sell
0
Current: 1.750
sliders
Low
0
Averages
0
High
0
0
Current: 1.750
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch